00:34 on June 22, 2022, Beijing time, Nanoviricides Inc (NNVC.us) shares fluctuated, with the share price rising 10.95%. As of press time, the stock was trading at US $2.23 per share, with a turnover of 25050 sharesTurnover rate0.22%, amplitude 9.95%.

Recent financial data show that the stock has an operating income of $0.00.Net profit-$1.79 million, earnings per share-$0.16Gross profit-$181559.00, with a price-to-earnings ratio of-2.99.

In terms of agency rating, 100% of the brokerages gave buy advice and no brokerage gave hold and sell advice among all the 1 rating agencies.

The biotech industry in which Nanoviricides Inc shares are located rose 2.31 per cent as a whole. Among its related stocks, Valneva Se, Clovis Oncology Inc and Reviva Pharmaceuticals Holdings Inc C/Wts 25 racer 12 Universe 2025 (To Pur Com) rose a lot, while Clovis Oncology Inc, Comera Life Sciences Holdings Inc and Mereo Biopharma Group Plc were more active, with turnover rates of 53.35%, 50.07% and 20.85%, respectively. The related stocks with larger amplitudes were Clovis Oncology Inc, Comera Life Sciences Holdings Inc C/Wts 15max 03Universe 2027 (To Pur Com) and Comera Life Sciences Holdings Inc. The amplitudes were 93.22%, 46.69% and 45.27%, respectively.

About Nanoviricides Inc: Nanoviricides Inc is a nano-biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic agents to advance the treatment of patients with life-threatening viral infections. The company is committed to applying nanomedical technology to the complex problems of viral diseases. It focuses its research and clinical programs on specific antiviral treatments and seeks to increase its existing product portfolio through its internal discovery, clinical research and development programs, and licensing strategies.

(the above content is completed by Money Call, a self-selected intelligent machine writer, and is only used as a reference for users to look at the market, not as a basis for transaction. )